Modular Medical grants stock options to director

Modular Medical, Inc. director and 10% owner C. Frank Morgan received new stock option awards as part of his outside director compensation.

Rhea-AI Filing Summary

Modular Medical, Inc. director and 10% owner C. Frank Morgan received new stock option awards as part of his outside director compensation. On June 30, 2026, he was granted options for 250 shares of common stock and a separate grant for 62 shares, each with an exercise price of $4.88 per share. The footnotes state these options were granted under the company’s Outside Director Compensation Plan and were fully vested and exercisable on the grant date. Following the grants, his reported beneficial ownership for these option classes is 312 options for one class and 62 options for the other.

Insider Trade Summary

Grant/Award: 312 shares

Grant/Award 2 txns

Insider FRANK MORGAN C.

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	62	$0.00	$0.00
Grant/Award	Option to purchase common stock	250	$0.00	$0.00

Holdings After Transaction: Option to purchase common stock — 312 contracts (Direct)

Footnotes (2)

1. F1. The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.
2. F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Option grant size 1: 250 options Option grant size 2: 62 options Exercise price: $4.88 per share +3 more

6 metrics

Option grant size 1 250 options Grant of options to purchase common stock on June 30, 2026

Option grant size 2 62 options Additional grant of options on June 30, 2026

Exercise price $4.88 per share Conversion or exercise price for both option grants

Expiration date June 30, 2036 Expiration for each option grant

Options owned (class 1) 312 options Total beneficial ownership of this option class after transaction

Options owned (class 2) 62 options Total beneficial ownership of second option class after transaction

Key Terms

Outside Director Compensation Plan, fully vested and exercisable, beneficial ownership, derivative security, +1 more

5 terms

Outside Director Compensation Plan financial

"The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan"

fully vested and exercisable financial

"the options were fully vested and exercisable on the grant date"

beneficial ownership financial

"column 9 reports only total beneficial ownership of the "class" of derivative security"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

derivative security financial

"beneficial ownership of the "class" of derivative security reported in column 1"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting terms financial

"Options that have different exercise prices or vesting terms are not considered to be of the same "class.""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did C. Frank Morgan report in this Modular Medical (MODD) Form 4?

C. Frank Morgan reported receiving two grants of stock options to purchase Modular Medical common shares. The awards were issued under the Outside Director Compensation Plan and represent routine, compensation-related acquisitions rather than open-market purchases or sales of stock.

How many stock options did C. Frank Morgan receive from Modular Medical (MODD)?

He received one grant for 250 options and a second grant for 62 options. Each option relates to one share of Modular Medical common stock, giving him additional equity-based compensation tied directly to the company’s share performance over time.

What is the exercise price of the options granted to the Modular Medical (MODD) director?

Both option grants carry an exercise price of $4.88 per share. This means Morgan can later buy Modular Medical common stock at $4.88, regardless of the market price at the time of exercise, subject to the options’ terms and expiration.

When do C. Frank Morgan’s Modular Medical (MODD) options expire?

Each option grant is scheduled to expire on June 30, 2036. After that date the options can no longer be exercised. The relatively long term gives the director an extended period to decide if and when to exercise the options.

Were the Modular Medical (MODD) options to C. Frank Morgan vested immediately?

Yes. The footnotes explain the options were fully vested and exercisable on the grant date. This immediate vesting means Morgan could choose to exercise the options any time before their June 30, 2036 expiration, subject to applicable company and legal requirements.

How many options does C. Frank Morgan beneficially own in Modular Medical (MODD) after these grants?

After these grants, he is shown as beneficially owning 312 options in one option class and 62 in another. The filing notes that options with different exercise prices or vesting terms are reported as different classes of derivative securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 01:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANK MORGAN C.

(Last) (First) (Middle)

2 CALLE CANDINA, #1701

(Street)

SAN JUAN PUERTO RICO 00907

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock(1)	$4.88	06/30/2026		A		62		06/30/2026	06/30/2036	Common Stock	62	(1)	62(2)	D
Option to purchase common stock(1)	$4.88	06/30/2026		A		250		06/30/2026	06/30/2036	Common Stock	250	(1)	312(2)	D

Explanation of Responses:

1. The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	Morgan C. Frank By: /s/ Morgan C. Frank	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)